- Mission [1]
- FDA's strategic priorities in responding to the public health challenges of the 21st century are to advance regulatory science
and innovation; strengthen the safety and integrity of the global supply chain; strengthen compliance and enforcement activities
to support public health; expand efforts to meet the needs of special populations; advance medical countermeasures and emergency
preparedness; advance food safety and nutrition; promote public health by advancing the safety and effectiveness of medical
products; establish an effective tobacco regulation, prevention, and control program; and manage for organizational excellence
and accountability. The National Mammography Quality Assurance Advisory Committee (NMQAAC)advises the Food and Drug Administration
on the following items, thereby helping FDA meet Objective 3 of Empowering Consumers by improving and increasing FDA-initiated
health benefit/risk information:(A)developing appropriate quality standards and regulations for mammography facilities; (B)developing
appropriate standards and regulations for bodies accrediting mammography facilities under this program; (C)developing regulations
with respect to sanctions;(D)developing procedures for monitoring compliance with standards;(E)establishing a mechanism to
investigate consumer complaints;(F)reporting new developments concerning breast imaging which should be considered in the
oversight of mammography facilities;(G)determining whether there exists a shortage of mammography facilities in rural and
health professional shortage areas and determining the effects of personnel on access to the services of such facilities in
such areas; (H)determining whether there will exist a sufficient number of medical physicists after October 1, 1999; and (I)determining
the costs and benefits of compliance with these requirements.
|
